Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
- PMID: 32297671
- PMCID: PMC7262036
- DOI: 10.1111/bjh.16659
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
Abstract
We explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PII) and disease evolution in patients with (corona virus disease 2019) COVID-19. A total of 123 patients with COVID-19 were divided into mild and severe groups. Lymphocyte subsets and cytokines were detected on the first day of hospital admission and lung computed tomography results were quantified by PII. Difference analysis and correlation analysis were performed on the two groups. A total of 102 mild and 21 severe patients were included in the analysis. There were significant differences in cluster of differentiation 4 (CD4+ T), cluster of differentiation 8 (CD8+ T), interleukin 6 (IL-6), interleukin 10 (IL-10) and PII between the two groups. There were significant positive correlations between CD4+ T and CD8+ T, IL-6 and IL-10 in the mild group (r2 = 0·694, r 2 = 0·633, respectively; P < 0·01). After 'five-in-one' treatment, all patients were discharged with the exception of the four who died. Higher survival rates occurred in the mild group and in those with IL-6 within normal values. CD4+ T, CD8+ T, IL-6, IL-10 and PII can be used as indicators of disease evolution, and the PII can be used as an independent indicator for disease progression of COVID-19.
Keywords: coronavirus infected disease; cytokines; disease classification; lymphocyte subsets; pulmonary inflammatory index.
© 2020 British Society for Haematology and John Wiley & Sons Ltd.
Conflict of interest statement
All authors declare no conflicts of interest.
Figures
Similar articles
-
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.J Clin Immunol. 2020 Oct;40(7):960-969. doi: 10.1007/s10875-020-00821-7. Epub 2020 Jul 13. J Clin Immunol. 2020. PMID: 32661797 Free PMC article.
-
The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.PLoS One. 2020 Sep 25;15(9):e0239532. doi: 10.1371/journal.pone.0239532. eCollection 2020. PLoS One. 2020. PMID: 32976531 Free PMC article.
-
The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Life Sci. 2020 Oct 1;258:118167. doi: 10.1016/j.lfs.2020.118167. Epub 2020 Jul 29. Life Sci. 2020. PMID: 32735885 Free PMC article.
-
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.Pharmacol Res. 2020 Sep;159:104946. doi: 10.1016/j.phrs.2020.104946. Epub 2020 May 23. Pharmacol Res. 2020. PMID: 32450346 Free PMC article. Review.
-
Hematological findings in coronavirus disease 2019: indications of progression of disease.Ann Hematol. 2020 Jul;99(7):1421-1428. doi: 10.1007/s00277-020-04103-5. Epub 2020 Jun 3. Ann Hematol. 2020. PMID: 32495027 Free PMC article. Review.
Cited by
-
Impact of the 2019 Coronavirus Infectious Disease (COVID-19) pandemic on onset to door time and admissions of new onset acute ischemic stroke in a tertiary care level hospital in North India.J Family Med Prim Care. 2022 Jun;11(6):3217-3223. doi: 10.4103/jfmpc.jfmpc_2398_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119293 Free PMC article.
-
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.Can J Neurol Sci. 2021 Jan;48(1):9-24. doi: 10.1017/cjn.2020.173. Epub 2020 Aug 5. Can J Neurol Sci. 2021. PMID: 32753076 Free PMC article. Review.
-
Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can.Front Immunol. 2021 Oct 13;12:726283. doi: 10.3389/fimmu.2021.726283. eCollection 2021. Front Immunol. 2021. PMID: 34721388 Free PMC article.
-
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.Int J Mol Sci. 2020 May 8;21(9):3330. doi: 10.3390/ijms21093330. Int J Mol Sci. 2020. PMID: 32397174 Free PMC article. Review.
-
Laboratory biomarkers associated with COVID-19 severity and management.Clin Immunol. 2020 Dec;221:108614. doi: 10.1016/j.clim.2020.108614. Epub 2020 Oct 22. Clin Immunol. 2020. PMID: 33153974 Free PMC article.
References
-
- General Office of the National Health and Family Planning Commission . Diagnosis and treatment of pneumonia with a new coronavirus infection (trial version 5). Chin J Integr Tradit West Med. 2020:1–3.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials